Inspire Medical Systems Inc (INSP)
Inspire Medical Systems, Inc. is a healthcare technology company focused on developing and commercializing minimally invasive treatment options for patients with obstructive sleep apnea (OSA) in the United States and other markets. Its principal product is the Inspire system, a neurostimulation therapy designed for adults with moderate to severe OSA. The company also works on a closed-loop solution that monitors breathing and delivers mild hypoglossal nerve stimulation to help keep the airway open. Incorporated in 2007, Inspire Medical Systems is headquartered in Golden Valley, Minnesota, and its common stock is listed on the New York Stock Exchange under the symbol INSP.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-INSP
|
$70.30
|
34.3% Upside
|
Undervalued
|
$52.38
|
0.1% Upside
|
Fair
|
Great
|
—
|
—
|
—
|
0.0%
|
August 3, 2026
|
11.6x
|
1.9x
|
1.7x
|
1.535 B
|
1.129 B
|
1.9%
|
88.4%
|
9.3
|
—
|
73.7%
|
